These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy. Maccariello ER, Genelhu de Abreu Fagundes V, Francischetti EA. Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765 [Abstract] [Full Text] [Related]
4. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension. Pittrow DB, Antlsperger A, Welzel D, Wambach G, Schardt W, Weidinger G. Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699 [Abstract] [Full Text] [Related]
5. Concomitant administration of isradipine and spirapril prevents reduction of renal function induced by acute administration of spirapril in patients with reduced renal function. Wittenberg C, Erman A, Shohat J, Boner G. Blood Press Suppl; 1994 Nov; 1():48-9. PubMed ID: 8205299 [Abstract] [Full Text] [Related]
9. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril]. Haufe CC, Sierakowski B, Jansa U, Stein G. Med Klin (Munich); 1994 Aug 15; 89(8):416-20. PubMed ID: 7968874 [Abstract] [Full Text] [Related]
10. Spirapril in chronic renal failure. Stein G, Sierakowski B, Jansa U, Haufe CC. Blood Press Suppl; 1994 Aug 15; 2():54-60. PubMed ID: 8061847 [Abstract] [Full Text] [Related]
11. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA. J Hypertens; 1992 Aug 15; 10(8):803-12. PubMed ID: 1325513 [Abstract] [Full Text] [Related]
12. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Nørgaard K, Jensen T, Christensen P, Feldt-Rasmussen B. Blood Press; 1993 Dec 15; 2(4):301-8. PubMed ID: 8173700 [Abstract] [Full Text] [Related]
15. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension. Noble S, Sorkin EM. Drugs; 1995 May 15; 49(5):750-66. PubMed ID: 7601014 [Abstract] [Full Text] [Related]
17. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats. Fabris B, Candido R, Armini L, Fischetti F, Calci M, Bardelli M, Fazio M, Campanacci L, Carretta R. J Hypertens; 1999 Dec 15; 17(12 Pt 2):1925-31. PubMed ID: 10703891 [Abstract] [Full Text] [Related]
19. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor. van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI. J Cardiovasc Pharmacol; 1995 Jan 15; 25(1):105-12. PubMed ID: 7723338 [Abstract] [Full Text] [Related]
20. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Alonso I, Fernández JR. Chronobiol Int; 2010 May 15; 27(3):560-74. PubMed ID: 20524801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]